erythromycin has been researched along with diosmetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutour, R; Poirier, D | 1 |
| Chan, BC; Fung, KP; Gong, H; Ip, M; Jolivalt, C; Lau, CB; Leung, PC; Lui, SL; Reiner, NE; See, RH | 1 |
1 review(s) available for erythromycin and diosmetin
| Article | Year |
|---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
1 other study(ies) available for erythromycin and diosmetin
| Article | Year |
|---|---|
Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Diosmin; Dose-Response Relationship, Drug; Drug Synergism; Erythromycin; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyruvate Kinase | 2013 |